NURO News and Press, NeuroMetrix Inc. From 07/23/20

NeuroMetrix, Inc. (NURO) Q2 2020 Earnings Conference Call July 23, 2020, 8:00 am ET Company Participants Thomas Higgins - SVP & CFO Shai Gozani - President & CEO Conference Call Participants Presentation Operator Good morning and welcome to the NeuroMetrix Sec...

NeuroMetrix (NASDAQ: NURO ) : Q2 net loss of $0.9M More news on: NeuroMetrix, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

WOBURN, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2020. The Company is a leading developer of neurostimulation-based medical devices that are used to diagnose and treat chronic he...

WOBURN, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2020 second quarter financial results before the opening of the market on Thursday, July 23, 2020. The Company will host a conference call at 8:00 a.m., Eastern Time o...

WOBURN, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction test for evaluation of peripheral neuropathies such as diabetic peripheral neuropathy (DPN). D...

Milestone Scientific (NYSEMKT: MLSS )  -20%  after pricing equity offering. More news on: Milestone Scientific Inc., DBV Technologies S.A., Ideanomics, Inc., Stocks on the move, , Read more ...

Nano cap NeuroMetrix ( NURO +7.2% ) inks an agreement with Biomedix to comarket its  DPNCheck  device for peripheral neuropathy detection in the Medicare Advantage and other value-based care markets. More news on: NeuroMetrix, Inc., Healthcare stocks news, Stocks on the move,...

WOBURN, Mass., June 25, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has signed a collaboration agreement with Biomedix to comarket DPNCheck for peripheral neuropathy detection within Medicare Advantage and other value-based care markets. NeuroMetrix and ...

4 Penny Stocks Trading Under $2.50 Right Now What are penny stocks ? This is a great question if you’re new to trade small-cap and micro-cap stocks . Based on the traditional definition of penny stocks , these are shares of public companies trading for less than $5. While there may b...

WOBURN, Mass., June 10, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has launched a marketing initiative focusing on chronic knee pain.  This effort includes direct-to-consumer digital marketing as well as informing physicians and other health ...